Incorporated in 2008, IMBiotechnologies Ltd (IMB) is a privately held Canadian medical device company located in Edmonton, Alberta focused on the commercialization of medical products in the area of embolotherapy. IMB’s mission is to create and commercialize innovative products that treat human disease and improve quality of life.
President, Chief Executive Officer, & Co-Founder
Mr. Stewart has broad experience in the medical device and biopharmaceutical sector and has held multiple positions as VP Research, VP Drug Development, Senior VP Operations, and Chief Operating Officer. He has over 35 publications in peer-reviewed medical journals and is an inventor on several issued patents including IMB’s intellectual property.
Chief Operating Officer & Co-Founder
Dr. Griffith has over thirty years of experience in biotechnology, developing therapeutic products and medical devices for the treatment of human disease conditions. He has had multiple positions in three different companies with ever-increasing responsibilities and acquired extensive hands-on experience in creating, managing and leading highly productive and effective teams in discovery research, preclinical toxicology, product development, manufacturing, business development. He has held Executive positions in project management, business development, product development and manufacturing. Dr. Griffith has dual citizenship in Canada and the US.
Ms. Yang has over 9 years of experience as a quality assurance professional in a wide range of industries, including pharmaceutical, biotechnology, and medical devices. She has extensive experience managing Quality Assurance systems, with specific expertise in root cause analysis and computer validation. Ms. Yang holds a MSc in Applied Chemistry from East China University of Science and Technology.